522 related articles for article (PubMed ID: 8464897)
1. Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
Apasov S; Sitkovsky M
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2837-41. PubMed ID: 8464897
[TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class I-specific and -restricted killing of beta 2-microglobulin-deficient cells by CD8+ cytotoxic T lymphocytes.
Glas R; Franksson L; Ohlén C; Höglund P; Koller B; Ljunggren HG; Kärre K
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11381-5. PubMed ID: 1454824
[TBL] [Abstract][Full Text] [Related]
3. Development and antigen specificity of CD8+ cytotoxic T lymphocytes in beta 2-microglobulin-negative, MHC class I-deficient mice in response to immunization with tumor cells.
Apasov SG; Sitkovsky MV
J Immunol; 1994 Mar; 152(5):2087-97. PubMed ID: 8133027
[TBL] [Abstract][Full Text] [Related]
4. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
Glas R; Ohlén C; Höglund P; Kärre K
J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
[TBL] [Abstract][Full Text] [Related]
5. Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cells.
Jhaver KG; Rao TD; Frey AB; Vukmanović S
J Immunol; 1995 Jun; 154(12):6252-61. PubMed ID: 7759863
[TBL] [Abstract][Full Text] [Related]
6. Control of thymus-independent intestinal intraepithelial lymphocytes by beta 2-microglobulin.
Neuhaus O; Emoto M; Blum C; Yamamoto S; Kaufmann SH
Eur J Immunol; 1995 Aug; 25(8):2332-9. PubMed ID: 7664795
[TBL] [Abstract][Full Text] [Related]
7. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
8. CD4+ and CD8+ alpha beta, and gamma delta T cells are cytotoxic effector cells of beta 2-microglobulin-deficient mice against cells having normal MHC class I expression.
Udaka K; Marusić-Galesić S; Walden P
J Immunol; 1994 Sep; 153(6):2843-50. PubMed ID: 7915743
[TBL] [Abstract][Full Text] [Related]
9. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.
Muller D; Koller BH; Whitton JL; LaPan KE; Brigman KK; Frelinger JA
Science; 1992 Mar; 255(5051):1576-8. PubMed ID: 1347959
[TBL] [Abstract][Full Text] [Related]
10. Differential reactivity of residual CD8+ T lymphocytes in TAP1 and beta 2-microglobulin mutant mice.
Ljunggren HG; Van Kaer L; Ashton-Rickardt PG; Tonegawa S; Ploegh HL
Eur J Immunol; 1995 Jan; 25(1):174-8. PubMed ID: 7843229
[TBL] [Abstract][Full Text] [Related]
11. Alpha beta TCR+ cells are a minimal fraction of peripheral CD8+ pool in MHC class I-deficient mice.
Nesić D; Santori FR; Vukmanović S
J Immunol; 2000 Aug; 165(4):1896-901. PubMed ID: 10925270
[TBL] [Abstract][Full Text] [Related]
12. CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes.
Zhang XL; Zhao S; Borenstein SH; Liu Y; Jayabalasingham B; Chamberlain JW
J Exp Med; 2001 Sep; 194(5):685-93. PubMed ID: 11535636
[TBL] [Abstract][Full Text] [Related]
13. Beta 2M-/- knockout mice contain low levels of CD8+ cytotoxic T lymphocyte that mediate specific tumor rejection.
Lamousé-Smith E; Clements VK; Ostrand-Rosenberg S
J Immunol; 1993 Dec; 151(11):6283-90. PubMed ID: 8245467
[TBL] [Abstract][Full Text] [Related]
14. Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype.
Lamousé-Smith E; McCarthy SA
Cell Immunol; 1997 Aug; 179(2):107-15. PubMed ID: 9268494
[TBL] [Abstract][Full Text] [Related]
15. CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.
Dalloul AH; Ngo K; Fung-Leung WP
Eur J Immunol; 1996 Jan; 26(1):213-8. PubMed ID: 8566069
[TBL] [Abstract][Full Text] [Related]
16. Development of CD8 alpha alpha+ intestinal intraepithelial T cells in beta 2-microglobulin- and/or TAP1-deficient mice.
Fujiura Y; Kawaguchi M; Kondo Y; Obana S; Yamamoto H; Nanno M; Ishikawa H
J Immunol; 1996 Apr; 156(8):2710-5. PubMed ID: 8609387
[TBL] [Abstract][Full Text] [Related]
17. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells.
Koller BH; Marrack P; Kappler JW; Smithies O
Science; 1990 Jun; 248(4960):1227-30. PubMed ID: 2112266
[TBL] [Abstract][Full Text] [Related]
18. MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice.
Ljunggren HG; Van Kaer L; Sabatine MS; Auchincloss H; Tonegawa S; Ploegh HL
Int Immunol; 1995 Jun; 7(6):975-84. PubMed ID: 7577806
[TBL] [Abstract][Full Text] [Related]
19. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells.
Eichelberger M; Allan W; Zijlstra M; Jaenisch R; Doherty PC
J Exp Med; 1991 Oct; 174(4):875-80. PubMed ID: 1919440
[TBL] [Abstract][Full Text] [Related]
20. Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism.
Christianson GJ; Brooks W; Vekasi S; Manolfi EA; Niles J; Roopenian SL; Roths JB; Rothlein R; Roopenian DC
J Immunol; 1997 Nov; 159(10):4781-92. PubMed ID: 9366402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
